|Articles|January 1, 2008
Medicare claims analysis
The rise in biopsy-related skin procedures appears medically justified, although further research is needed, according to a recent analysis of Medicare claims data.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement














